Clinical observations have shown that the incidence of AF after coronary artery bypass grafting was significantly reduced after oral administration of berberine, with a significant reduction in serum lipopolysaccharide, CRP, and IL-6 levels (91). The gene discussed is IL6; the disease is atrial fibrillation.